HCA Healthcare Inc (NYSE:HCA) Shares Sold by Janus Henderson Group PLC

Janus Henderson Group PLC decreased its position in shares of HCA Healthcare Inc (NYSE:HCA) by 17.5% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,954,915 shares of the company’s stock after selling 413,632 shares during the quarter. Janus Henderson Group PLC owned about 0.57% of HCA Healthcare worth $264,249,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Hussman Strategic Advisors Inc. raised its stake in shares of HCA Healthcare by 88.7% during the second quarter. Hussman Strategic Advisors Inc. now owns 20,000 shares of the company’s stock valued at $2,703,000 after purchasing an additional 9,400 shares in the last quarter. Royal London Asset Management Ltd. raised its stake in shares of HCA Healthcare by 5.1% during the second quarter. Royal London Asset Management Ltd. now owns 236,260 shares of the company’s stock valued at $31,948,000 after purchasing an additional 11,512 shares in the last quarter. AGF Investments LLC raised its stake in shares of HCA Healthcare by 154.2% during the second quarter. AGF Investments LLC now owns 14,093 shares of the company’s stock valued at $1,905,000 after purchasing an additional 8,550 shares in the last quarter. Alpha Windward LLC raised its stake in shares of HCA Healthcare by 50.9% during the second quarter. Alpha Windward LLC now owns 608 shares of the company’s stock valued at $89,000 after purchasing an additional 205 shares in the last quarter. Finally, Los Angeles Capital Management & Equity Research Inc. raised its stake in shares of HCA Healthcare by 368.9% during the second quarter. Los Angeles Capital Management & Equity Research Inc. now owns 71,463 shares of the company’s stock valued at $9,660,000 after purchasing an additional 56,224 shares in the last quarter. 70.23% of the stock is owned by institutional investors.

HCA Healthcare stock traded down $3.40 during midday trading on Wednesday, hitting $124.50. The company’s stock had a trading volume of 169,427 shares, compared to its average volume of 1,741,663. The business’s 50-day simple moving average is $135.68. HCA Healthcare Inc has a 12 month low of $110.31 and a 12 month high of $147.42. The firm has a market capitalization of $42.86 billion, a P/E ratio of 12.74, a PEG ratio of 1.09 and a beta of 0.85.



HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, July 30th. The company reported $2.21 EPS for the quarter, missing the consensus estimate of $2.49 by ($0.28). HCA Healthcare had a negative return on equity of 135.90% and a net margin of 7.46%. The business had revenue of $12.60 billion during the quarter, compared to the consensus estimate of $12.61 billion. During the same quarter last year, the firm posted $2.29 earnings per share. HCA Healthcare’s revenue was up 9.3% compared to the same quarter last year. As a group, equities research analysts anticipate that HCA Healthcare Inc will post 10.35 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Tuesday, September 3rd will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 1.29%. The ex-dividend date of this dividend is Friday, August 30th. HCA Healthcare’s dividend payout ratio (DPR) is presently 16.38%.

A number of equities research analysts recently weighed in on HCA shares. Jefferies Financial Group set a $158.00 price objective on shares of HCA Healthcare and gave the company a “buy” rating in a research note on Wednesday, April 17th. Barclays cut their price objective on shares of HCA Healthcare from $155.00 to $145.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 17th. Mizuho set a $153.00 price objective on shares of HCA Healthcare and gave the company a “buy” rating in a research note on Wednesday, July 31st. Goldman Sachs Group upgraded shares of HCA Healthcare from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $147.00 to $160.00 in a research note on Wednesday, July 10th. Finally, Raymond James upgraded shares of HCA Healthcare from a “market perform” rating to an “outperform” rating and lifted their price objective for the company from $115.00 to $135.00 in a research note on Tuesday, April 23rd. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and seventeen have given a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $153.35.

In related news, major shareholder Patricia F. Elcan acquired 250 shares of the business’s stock in a transaction on Tuesday, August 6th. The shares were purchased at an average price of $124.10 per share, for a total transaction of $31,025.00. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, SVP Robert A. Waterman sold 33,786 shares of the business’s stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $134.98, for a total value of $4,560,434.28. Following the sale, the senior vice president now owns 279,551 shares in the company, valued at approximately $37,733,793.98. The disclosure for this sale can be found here. 2.70% of the stock is currently owned by insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Read More: Front-End Load

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.